What It Actually Feels Like to Be on Wegovy

The first injection and what happens next

Picture this: a small box arrives with DPD tracking, plain and unbranded, with the Wegovy pen inside. The pen is pre-filled, pre-set to 0.25mg, and the injection itself takes seconds. What follows in the next day or two is where experiences start to diverge.

Some people feel nothing unusual in the first week. Others notice nausea fairly quickly, typically peaking a few hours after the injection, sometimes lasting a day or two. A smaller number experience looser stools or constipation. These are the body's response to semaglutide slowing how quickly food moves through the stomach, a mechanism the NHS semaglutide medicines page describes alongside the full side-effect picture.

Appetite often changes before any weight shifts. Many people describe it as a reduction in intrusive thoughts about food, or finding they feel full after eating much less than usual. If you want a fuller picture of what it is like to be on Wegovy day to day, that shift in hunger is one of the things people find most surprising.

The 0.25mg starting dose is there purely to let your system settle, not to drive weight loss. Knowing that early on helps manage expectations during the adjustment phase.

How the experience changes as the dose increases

Wegovy's dose steps upward roughly every four weeks, from 0.25mg to 0.5mg, then 1mg, 1.7mg, and eventually 2.4mg maintenance. Each step can reset the side-effect clock slightly. Nausea that faded at 0.25mg may return briefly when the dose increases, then settle again.

By the time most people reach 1mg or higher, the pattern tends to stabilise: appetite suppression becomes more consistent, GI symptoms become more predictable and less intrusive, and energy levels often normalise. Fatigue and headaches, which can appear early on, tend to resolve once the body has had four to six weeks at a given dose.

A minority of people find the side effects persistent regardless of dose. That is a clinical conversation with your prescriber, not something to push through alone. If you have questions about how treatment is managed at different stages, the Wegovy overview on this site covers the licensed schedule in more detail, and our clinical team reviews every repeat order before it is dispensed.

One thing worth knowing about what Wegovy feels like at higher doses: many people report a kind of metabolic steadiness, fewer blood sugar dips, less reactive hunger after meals. That is the GLP-1 pathway working as intended.

What Wegovy does not feel like

Some people arrive expecting a stimulant effect, raised heart rate, jitteriness, the feeling of something actively suppressing appetite by force. Wegovy does not work that way. There is no buzz. The effect is more like a background recalibration of hunger signals, which can make it feel almost underwhelming at first, until the cumulative impact on eating patterns becomes apparent.

People occasionally ask whether they will feel the injection. The pen delivers the dose subcutaneously into the abdomen, thigh, or upper arm. Most people describe it as minimal, a brief sting at most. Rotating sites helps reduce any localised irritation.

There is also the psychological side of what Wegovy feels like, which tends to get less attention. Some people report a genuine sense of relief at not being preoccupied by food. Others go through a period of adjustment when eating patterns that felt fixed for years start to shift. The semaglutide information page covers the mechanism behind these changes if you want the clinical picture.

If at any point the treatment stops feeling effective, it is worth reading about what to do when Wegovy seems to stop working before drawing conclusions, plateau periods are common and often have a clinical explanation.

Side effects worth knowing about before you start

The GI effects dominate early experience for most people: nausea, vomiting, diarrhoea, constipation, reflux, and burping are all listed in the prescribing information. Most are mild to moderate and time-limited. Staying hydrated matters, persistent vomiting or diarrhoea can affect kidney function if dehydration sets in.

There are symptoms that warrant prompt medical attention. Severe, persistent stomach pain that travels to the back, with or without vomiting, can be a sign of acute pancreatitis. Following a safety review, the MHRA issued a Drug Safety Update in January 2026 highlighting pancreatitis as an infrequent but serious risk with GLP-1 medicines. If you experience this, stop the medicine and get medical help the same day.

Other signs that need prompt attention include symptoms of a severe allergic reaction, significant abdominal pain pointing to gallbladder problems, or signs of serious dehydration. Wegovy is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. It is not licensed for people under 18.

For a broader picture of cost and access (which shapes what treatment feels sustainable long-term) the guide to accessing Wegovy in the UK is worth reading alongside the clinical detail here. Treatment always starts with a consultation; pricing and what is included in a private prescription are covered there.